At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

RAS mutations are among the most common drivers in cancer, particularly in pancreatic, colorectal, and lung tumors. Despite that, directly targeting RAS proteins proved extremely difficult for years, ...

PARIS — RAS Luxury Skincare, the Indian farm-to-face brand, closed a 65 Crores, or $7.5 million, Series B funding round led by Dabur Ventures. Dabur Ventures is the venture arm of the largest ...

This comedic sketch features a car modified with a cheese wheel to endlessly grate cheese onto a salad! It's a dairy-filled dream for cheese lovers. Donald Trump seeks court order against own DOJ to ...

The HEC Jobs 2025 Apply Online for Assistant Directors, Directors & Others Higher Education Commission Published in Express Newspaper on 27 July 2025 and Last date to apply is 11 August 2025. The ...

Abstract: The world is facing unavoidable disaster challenges, especially floods in Thailand, these inundations have been becoming increasingly difficult to manage each year. Therefore, a preliminary ...

Kent Lee Platte created a metric called "Relative Athletic Scores" (RAS) that measures how prospects stack up against other players at their position based on combined athletic categories like height, ...

The U.S. Army Corps of Engineers Nashville District is seeking public input on a proposed modification to the Cleveland Flood Risk Management Project as part of a supplemental environmental assessment ...

Alexander I. Spira, MD, PhD, FACP, discusses the next steps in the clinical development of zoldonrasib for patients with KRAS G12D pancreatic ductal adenocarcinoma based on preliminary findings.

NIH researchers found that mutant RAS genes can promote cancer through a novel mechanism, leading to enhanced tumor growth. This discovery suggests new combined drug approaches may be more effective ...

Arrhythmias are a major public health burden and a major cause of morbidity and mortality (Srinivasan and Schilling, 2018). Pharmacologic anti-arrhythmic agents targeting ion channel activity have ...